Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
The American Journal of Managed Care|September 19, 2022
Good health policy requires high-quality evidence. let's remember that with drug pricingMichael Ciarametaro, John Michael O'BrienJournal of Managed Care & Specialty Pharmacy|June 22, 2018
The Effect of Medical Technology Innovations on Patient Outcomes, 1990-2015: Results of a Physician SurveyDavid E Wamble, Michael Ciarametaro, Robert DuboisValue in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 1, 2021
The Dollar or Disease Burden: Caps on Healthcare Spending May Save Money, but at What "Cost" to Patients?Michael Ciarametaro, Katherine Houghton, David Wamble, et al.Health Affairs (Project Hope)|January 8, 2019
What's Been The Bang For The Buck? Cost-Effectiveness Of Health Care Spending Across Selected Conditions In The USDavid Wamble, Michael Ciarametaro, Katherine Houghton, et al.The American Journal of Managed Care|December 21, 2017
Insurance switching and mismatch between the costs and benefits of new technologiesDavid Cutler, Michael Ciarametaro, Genia Long, et al.Expert Review of Pharmacoeconomics & Outcomes Research|December 29, 2022
Medicaid best price reforms to enable innovative payment models for cell and gene therapiesCasey Quinn, Michael Ciarametaro, Brian Sils, et al.Expert Review of Pharmacoeconomics & Outcomes Research|January 31, 2022
What might have happened: the impact of interrupting entry of innovative drugs on disease outcomes in the United StatesWilliam Herring, Michael Ciarametaro, Josephine Mauskopf, et al.Population Health Management|December 5, 2018
Utilization of High-Cost Interventions for Targeted Clinical Conditions During the Early Stages of ACO Development in a Commercially Insured PopulationSiting Zhou, Michael Ciarametaro, Bingcao Wu, et al.Expert Review of Pharmacoeconomics & Outcomes Research|March 29, 2023
Value-based performance arrangements for chronic conditions: an economic simulation of Medicaid Drug Rebate Program reformsCasey Quinn, Michael Ciarametaro, Brian Sils, et al.Journal of Managed Care & Specialty Pharmacy|November 2, 2021
Health spending expenditures for commercial plans are predominantly concentrated among a small population of high-intensity consumers across settings of careMichael Ciarametaro, Michael Kleinrock, Allen Campbell, et al.Pageof 2